Cannabis Bioscience International Holdings (CBIH) Return on Sales (2022 - 2025)
Historic Return on Sales for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to 3.81%.
- Cannabis Bioscience International Holdings' Return on Sales fell 32500.0% to 3.81% in Q3 2025 from the same period last year, while for Aug 2025 it was 3.72%, marking a year-over-year decrease of 21500.0%. This contributed to the annual value of 1.84% for FY2025, which is 7300.0% up from last year.
- Cannabis Bioscience International Holdings' Return on Sales amounted to 3.81% in Q3 2025, which was down 32500.0% from 6.8% recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' Return on Sales registered a high of 0.56% during Q3 2024, and its lowest value of 10.16% during Q1 2025.
- In the last 4 years, Cannabis Bioscience International Holdings' Return on Sales had a median value of 3.24% in 2022 and averaged 4.09%.
- Per our database at Business Quant, Cannabis Bioscience International Holdings' Return on Sales skyrocketed by 43000bps in 2024 and then tumbled by -51500bps in 2025.
- Over the past 4 years, Cannabis Bioscience International Holdings' Return on Sales (Quarter) stood at 2.66% in 2022, then grew by 27bps to 1.95% in 2023, then surged by 51bps to 0.95% in 2024, then plummeted by -299bps to 3.81% in 2025.
- Its last three reported values are 3.81% in Q3 2025, 6.8% for Q2 2025, and 10.16% during Q1 2025.